In PLWH, decreased NK cell expression of NKp30 and NKp46 receptors has been reported, and appears to be a characteristic of CD56negCD16pos NK cells, reducing their cytokine production and cytotoxicity, notably against tumor target cells, as well as their ability to interact with other immune cells (84–86). The gene discussed is NCR3; the disease is neoplasm.